O, M., H, M., M, E., A, S., S, H., F, M., . . . MK, P. (2018). Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment. Bioengineering (Basel, Switzerland), 5(1), . https://doi.org/10.3390/bioengineering5010007
Chicago Style (17th ed.) CitationO, Montacir, Montacir H, Eravci M, Springer A, Hinderlich S, Mahboudi F, Saadati A, and Parr MK. "Bioengineering of RFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment." Bioengineering (Basel, Switzerland) 5, no. 1 (2018). https://doi.org/10.3390/bioengineering5010007.
MLA (9th ed.) CitationO, Montacir, et al. "Bioengineering of RFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment." Bioengineering (Basel, Switzerland), vol. 5, no. 1, 2018, https://doi.org/10.3390/bioengineering5010007.